These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5766895)

  • 21. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iyomycin, a new antitumor antibiotic from Streptomyces. IV. Experimental treatment of malignant tumors with iyomycins.
    Hoshino M; Umezawa I; Mimura Y; Hata T
    J Antibiot (Tokyo); 1967 Jan; 20(1):20-40. PubMed ID: 6072279
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on antitumor antibiotic 1588--IV. Metabolism and toxicity studies].
    Yang GZ
    Zhonghua Zhong Liu Za Zhi; 1983 Jan; 5(1):5-7. PubMed ID: 6189686
    [No Abstract]   [Full Text] [Related]  

  • 24. Toxicity and antitumor activity of niosomal bleomycin in tumor bearing mice.
    Naresh RA; Udupa N; Devi PU
    Indian J Exp Biol; 1996 Aug; 34(8):764-72. PubMed ID: 8979482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1.
    Malonne H; Farinelle S; Decaestecker C; Gordower L; Fontaine J; Chaminade F; Saucier JM; Atassi G; Kiss R
    Clin Cancer Res; 2000 Sep; 6(9):3774-82. PubMed ID: 10999772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
    Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
    J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differential determination of acridine derivatives].
    Yalçindag ON
    J Pharm Belg; 1971; 26(6):675-80. PubMed ID: 5142154
    [No Abstract]   [Full Text] [Related]  

  • 29. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
    Umezawa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of 1-nitro-9-aminoacridine derivatives.
    Hrabowska M; Mazerska Z; Lukowicz JP; Onoszko K; Ledóchowski A
    Arzneimittelforschung; 1982; 32(9):1013-6. PubMed ID: 6890816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antitumor activity of novel thioester derivatives of leinamycin.
    Kanda Y; Ashizawa T; Kakita S; Takahashi Y; Kono M; Yoshida M; Saitoh Y; Okabe M
    J Med Chem; 1999 Apr; 42(8):1330-2. PubMed ID: 10212117
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhancement of the recombinagenic and mutagenic activities of bleomycin in yeast by intercalation of acridine compounds into DNA.
    Hoffmann GR; Ronan MV; Sylvia KE; Tartaglione JP
    Mutagenesis; 2009 Jul; 24(4):317-29. PubMed ID: 19406902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differentiation by thin layer chromatography of pharmaceutical acridine derivatives].
    Yalçindag ON
    J Pharm Belg; 1971; 26(3):337-40. PubMed ID: 5155358
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of administration of a nitro acridine derivative on the activity of hydrolases in Sa-180 and internal organs in mice.
    Radzikowski C; Urbańska M; Michalik T; Myśliwski A; Hrabowska M
    Arch Immunol Ther Exp (Warsz); 1967; 15(1):148-52. PubMed ID: 6048225
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental study of antitumor activity of the antibiotic bruneomycin].
    Shorin VA; Rossolimo OK; Stanislavskaia MS; Pevzner NS; Shapovalova SP; Lepeshkina GN
    Antibiotiki; 1966 Aug; 11(8):683-91. PubMed ID: 6014957
    [No Abstract]   [Full Text] [Related]  

  • 36. New water-soluble duocarmycin derivatives: synthesis and antitumor activity of A-ring pyrrole compounds bearing beta-heteroarylacryloyl groups.
    Amishiro N; Nagamura S; Kobayashi E; Gomi K; Saito H
    J Med Chem; 1999 Feb; 42(4):669-76. PubMed ID: 10052974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis.
    Olano C; Méndez C; Salas JA
    Nat Prod Rep; 2009 May; 26(5):628-60. PubMed ID: 19387499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activity.
    Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Cozzi P; Geroni C; Mongelli N
    Farmaco; 1997 Dec; 52(12):711-6. PubMed ID: 9648274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antitumor properties of N-[2-(dimethylamino)ethyl]carboxamide derivatives of fused tetracyclic quinolines and quinoxalines: a new class of putative topoisomerase inhibitors.
    Deady LW; Kaye AJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1997 Jun; 40(13):2040-6. PubMed ID: 9207945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives.
    Bacherikov VA; Chang JY; Lin YW; Chen CH; Pan WY; Dong H; Lee RZ; Chou TC; Su TL
    Bioorg Med Chem; 2005 Dec; 13(23):6513-20. PubMed ID: 16140018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.